XML 104 R85.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation - Summary of Stock Options (Detail) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Feb. 09, 2016
2013 Stock Incentive Plan      
Stock Options      
Beginning balance, stock options, outstanding (in shares) 7,322,293    
Stock options, granted (in shares) 1,215,789    
Exercise of stock options, (in shares) 0    
Stock options, forfeited (in shares) (201,365)    
Stock options, canceled (in shares) (3,060,038)    
Ending balance, stock options, outstanding (in shares) 5,276,679 7,322,293  
Weighted- Average Exercise Price      
Beginning balance, weighted - average exercise price, outstanding (in usd per share) $ 11.62    
Weighted - average exercise price, granted (in usd per share) 7.99    
Weighted - average exercise price, exercised (in usd per share) 0    
Weighted - average exercise price, forfeited (in usd per share) 8.04    
Weighted - average exercise price, canceled (in usd per share) 12.23    
Ending balance, weighted - average exercise price, outstanding (in usd per share) $ 10.57 $ 11.62  
Stock Option Activity, Additional Disclosures      
Weighted - average remaining contractual term, outstanding 6 years 8 months 12 days    
Aggregate intrinsic value, outstanding $ 0    
Stock options, exercisable at December 31, 2019 (in shares) 3,688,733    
Weighted - average exercise price, exercisable at December 31, 2019 (in usd per share) $ 11.63    
Weighted - average remaining contractual term, exercisable at December 31, 2019 5 years 9 months 18 days    
Aggregate intrinsic value, exercisable at December 31, 2019 $ 0    
Stock options, expected to vest after December 31, 2019 (in shares) 1,587,946    
Weighted - average exercise price, expected to vest after December 31, 2019 (in usd per share) $ 8.12    
Weighted - average remaining contractual term, expected to vest after December 31, 2019 8 years 7 months 6 days    
Aggregate intrinsic value, expected to vest after December 31, 2019 $ 0    
Stock options, exercisable as of December 31, 2019 and expected to vest thereafter (in shares) 5,276,679    
Weighted - average exercise price, exercisable as of December 31, 2019 and expected to vest thereafter (in usd per share) $ 10.57    
Weighted - average remaining contractual term, exercisable as of December 31, 2019 and expected to vest thereafter 6 years 7 months 6 days    
Aggregate intrinsic value, exercisable as of December 31, 2019 and expected to vest thereafter $ 0    
Estimated fair value of the Company's common stock (in dollars per share) $ 4.70    
Constant Contact 2011 Stock Plan      
Stock Options      
Beginning balance, stock options, outstanding (in shares) 715,104    
Stock options, granted (in shares) 0 0  
Exercise of stock options, (in shares) (6,793)    
Stock options, forfeited (in shares) (27,281)    
Stock options, canceled (in shares) (147,483)    
Ending balance, stock options, outstanding (in shares) 533,547 715,104  
Weighted- Average Exercise Price      
Beginning balance, weighted - average exercise price, outstanding (in usd per share) $ 9.00    
Weighted - average exercise price, granted (in usd per share) 0    
Weighted - average exercise price, exercised (in usd per share) 4.81    
Weighted - average exercise price, forfeited (in usd per share) 9.53    
Weighted - average exercise price, canceled (in usd per share) 9.75    
Ending balance, weighted - average exercise price, outstanding (in usd per share) $ 8.83 $ 9.00  
Stock Option Activity, Additional Disclosures      
Weighted - average remaining contractual term, outstanding 2 years    
Aggregate intrinsic value, outstanding $ 19   $ 22,300
Stock options, exercisable at December 31, 2019 (in shares) 512,265    
Weighted - average exercise price, exercisable at December 31, 2019 (in usd per share) $ 8.79    
Weighted - average remaining contractual term, exercisable at December 31, 2019 1 year 10 months 24 days    
Aggregate intrinsic value, exercisable at December 31, 2019 $ 19    
Stock options, expected to vest after December 31, 2019 (in shares) 21,282    
Weighted - average exercise price, expected to vest after December 31, 2019 (in usd per share) $ 9.71    
Weighted - average remaining contractual term, expected to vest after December 31, 2019 3 years 7 months 6 days    
Aggregate intrinsic value, expected to vest after December 31, 2019 $ 0    
Stock options, exercisable as of December 31, 2019 and expected to vest thereafter (in shares) 533,547    
Weighted - average exercise price, exercisable as of December 31, 2019 and expected to vest thereafter (in usd per share) $ 8.83    
Weighted - average remaining contractual term, exercisable as of December 31, 2019 and expected to vest thereafter 2 years    
Aggregate intrinsic value, exercisable as of December 31, 2019 and expected to vest thereafter $ 19